fulvestrant has been researched along with Teratoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WC; Chang, YY; Chen, LC; Chen, LM; Chung, WM; Hung, YC; Lin, TY; Ma, WL; Wu, LY | 1 |
Chambon, P; Feil, R; Metzger, D; Wagner, J | 1 |
2 other study(ies) available for fulvestrant and Teratoma
Article | Year |
---|---|
Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
Topics: Cell Line, Tumor; Cell Movement; Estradiol; Estrogen Receptor alpha; Estrogens; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphorylation; Teratoma; Tissue Culture Techniques; Tumor Stem Cell Assay | 2014 |
Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Enzyme Induction; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Integrases; Kinetics; Mice; Molecular Sequence Data; Mutagenesis, Insertional; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Point Mutation; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Teratoma; Tumor Cells, Cultured; Viral Proteins | 1997 |